ContractUS Oncology Holdings, Inc. • June 18th, 2009 • Services-hospitals • New York
AMENDMENT NO. 7 dated as of June 3, 2009 (this “Amendment”), among US ONCOLOGY HOLDINGS, INC. (“Holdings”), US ONCOLOGY, INC. (the “Borrower”), the Lenders party hereto and JPMORGAN CHASE BANK, N.A., as Administrative Agent.
US ONCOLOGY, INC. $775,000,000 9.125% Senior Secured Notes Due 2017 Registration Rights AgreementUS Oncology Holdings, Inc. • June 18th, 2009 • Services-hospitals • New York
US Oncology, Inc., a corporation organized under the laws of Delaware (the “Issuer”), proposes to issue and sell to certain purchasers (the “Initial Purchasers”), for whom you (the “Representatives”) are acting as representatives, $775,000,000 principal amount of its Senior Secured Notes Due 2017 (the “Securities”), upon the terms set forth in the Purchase Agreement between the Issuer, the subsidiaries of the Issuer identified as guarantors in Schedule I to the Purchase Agreement (collectively, the “Initial Guarantors”) and the Representatives, dated as of June 4, 2009 (the “Purchase Agreement”), relating to the initial placement (the “Initial Placement”) of the Securities. To induce the Initial Purchasers to enter into the Purchase Agreement and to satisfy a condition to your obligations thereunder, the Issuer and the Guarantors agree with you for your benefit and the benefit of the holders from time to time of the Securities (including the Initial Purchasers) (each a “Holder” and, co
US ONCOLOGY, INC. Issuer and the Subsidiary Guarantors named herein 9.125% Senior Secured Notes Due 2017 INDENTURE DATED AS OF JUNE 18, 2009 WILMINGTON TRUST FSB TrusteeUS Oncology Holdings, Inc. • June 18th, 2009 • Services-hospitals • New York
INDENTURE dated as of June 18, 2009, among US Oncology, Inc., a Delaware corporation (the “Company”), the Subsidiary Guarantors (as defined herein) and Wilmington Trust FSB, a federal savings bank, as Trustee (the “Trustee”).
